BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21947493)

  • 1. Locally advanced mid/low rectal cancer with synchronous liver metastases.
    Viganò L; Karoui M; Ferrero A; Tayar C; Cherqui D; Capussotti L
    World J Surg; 2011 Dec; 35(12):2788-95. PubMed ID: 21947493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
    Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
    Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Bae HW; Kim HS; Yang SY; Kim HS; Shin SJ; Chang JS; Koom WS; Kim NK
    Eur J Surg Oncol; 2021 Nov; 47(11):2814-2820. PubMed ID: 34024668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases.
    Verhoef C; van der Pool AE; Nuyttens JJ; Planting AS; Eggermont AM; de Wilt JH
    Dis Colon Rectum; 2009 Jan; 52(1):23-30. PubMed ID: 19273952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor?
    Cellini C; Hunt SR; Fleshman JW; Birnbaum EH; Bierhals AJ; Mutch MG
    World J Surg; 2010 May; 34(5):1102-8. PubMed ID: 20177683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases.
    Ayez N; Burger JW; van der Pool AE; Eggermont AM; Grunhagen DJ; de Wilt JH; Verhoef C
    Dis Colon Rectum; 2013 Mar; 56(3):281-7. PubMed ID: 23392140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.
    Cho H; Kim JE; Kim KP; Yu CS; Kim JC; Kim JH; Lee MA; Jang HS; Oh ST; Kim SY; Oh JH; Kim DY; Hong YS; Kim TW
    Am J Clin Oncol; 2016 Dec; 39(6):623-629. PubMed ID: 27322695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
    Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
    Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases.
    Liu KT; Wan JF; Zhu J; Li GC; Sun WJ; Shen LJ; Cai SJ; Gu WL; Lian P; Zhang Z
    Cancer Radiother; 2016 Dec; 20(8):805-810. PubMed ID: 27777027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological strategies for middle and low rectal cancer with synchronous liver metastases.
    Sabbagh C; Cosse C; Ravololoniaina T; Chauffert B; Joly JP; Mauvais F; Regimbeau JM
    Int J Surg; 2015 Nov; 23(Pt A):186-93. PubMed ID: 26316155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastases in locally advanced rectal cancer undergoing curatively intended treatment.
    Mariathasan AB; Boye K; Dueland S; Flatmark K; Larsen SG
    Eur J Surg Oncol; 2021 Sep; 47(9):2377-2383. PubMed ID: 34049768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study.
    Slesser AA; Khan F; Chau I; Khan AZ; Mudan S; Tekkis PP; Brown G; Rao S
    Eur J Surg Oncol; 2015 Apr; 41(4):484-92. PubMed ID: 25638603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer.
    Butte JM; Gonen M; Ding P; Goodman KA; Allen PJ; Nash GM; Guillem J; Paty PB; Saltz LB; Kemeny NE; Dematteo RP; Fong Y; Jarnagin WR; Weiser MR; D'Angelica MI
    Cancer; 2012 Nov; 118(21):5414-23. PubMed ID: 22517058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases.
    Manceau G; Brouquet A; Bachet JB; Penna C; El Hajjam M; Rougier P; Nordlinger B; Benoist S
    Surgery; 2013 Sep; 154(3):528-35. PubMed ID: 23601902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis.
    Kim KH; Shin SJ; Cho MS; Ahn JB; Jung M; Kim TI; Park YS; Kim H; Kim NK; Koom WS
    Radiother Oncol; 2016 Feb; 118(2):369-74. PubMed ID: 26705682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.